Xerion Healthcare, a spin out from the University of Oxford, develops novel nanoparticle systems which act in conjunction with radiotherapy to enhance the effectiveness of the treatment of solid tumours.  Xerion is working to transform radiotherapy for cancer treatment using pioneering nanomedicine technology.

The company bankrupted on 15-May-2024.